Changes in Life Expectancy After Allogeneic Blood or Marrow Transplantation

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 9, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3676?guestAccessKey=3f852df3-f991-471c-82a1-43005d1ca1a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090921

  

What the Study Did: Researchers examined changes over four decades in life expectancy or risk of death after allogeneic (donated from another person) blood or marrow transplantation.

Authors: Smita Bhatia, M.D., M.P.H., of the University of Alabama at Birmingham, is the corresponding author.

 

(doi:10.1001/jamaoncol.2021.3676)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.